With nearly two decades of committed service to the peptide industry, Chinese Peptide Company(CPC) is the integrated CRO/CDMO peptide providers of high quality peptides for researchers and pharmaceutical companies all over the world. The CPC group is managed by peptide experts who have been actively pursuing peptide design and large scale manufacturing for more than 30 years in the industry. The CPC Group currently employs more than 600 chemists in Hangzhou, China and the United States has achieved many successful US FDA inspections, ISO-9001 and ISO-13485 certifications. The state-of-the-art, >70,000 ㎡ area of peptide facility is uniquely designed to handle research-grade peptides as well as cGMP grade peptides for clinical trials and API development from milligram to hundreds of kilogram scale.
● The First US FDA inspected GMP peptide facility in Asia (2011)
● CPC is highly experienced at synthesizing challenging peptide sequences and complex modifications designed to your exact specifications
● First choice of the peptide partners of the world's top 10 pharmaceutical companies and many esteemed scientific research institutions
CPC is your trusted global peptide CRO/CDMO partner and we support a diverse pipeline of peptide programs, in all clinical Phases, and manufacture a number of commercially approved peptides. Our experienced team of scientists have expertise with all relevant peptide modifications, and we support NCE development programs from early stage (R&D to pre-clinical) through commercialization, including process development and optimization, analytical method development and validation, CGMP API production and process validation, formulation development, stability studies and assistance with regulatory documentation to support IND and NDA submissions.